Pembrolizumab in combination with bevacizumab and oral cyclophosphamide in heavily pre-treated platinum-resistant ovarian cancer
Αngeliki Andrikopoulou, Michalis Liontos, Efthymia Skafida, Konstantinos Koutsoukos, Kleoniki Apostolidou, Maria Kaparelou, Angeliki Rouvalis, Garyfallia Bletsa, Meletios Α. Dimopoulos, Flora Zagouri
Topics & Concepts
MedicinePembrolizumabBevacizumabInternal medicineOncologyOvarian cancerCyclophosphamideChemotherapyOvarian carcinomaCancerGastroenterologyImmunotherapyOvarian cancer diagnosis and treatmentPARP inhibition in cancer therapyCancer Immunotherapy and Biomarkers